SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Fishbone Betsy

(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NEW YORK 10022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026
3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CLO and Secretary
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock15,021D
Common Stock50IBy Family Member
Common Stock8,336IBy Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (1)09/13/2031Common Stock9,944$72.83D
Stock Option (Right to Buy) (2)09/10/2029Common Stock19,012$77.04D
Stock Option (Right to Buy) (3)09/09/2030Common Stock16,612$78.03D
Stock Option (Right to Buy) (4)09/11/2033Common Stock9,392$84.06D
Stock Option (Right to Buy) (5)09/12/2032Common Stock6,848$106.34D
Explanation of Responses:
1. Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2023 grant date.
2. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.
3. Option became exercisable in one-third increments beginning on the first anniversary of the September 9, 2022 grant date.
4. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 11, 2025 grant date.
5. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2024 grant date.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kristine Hutchinson, Attorney-in-Fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)